“Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials” (2025) SKIN The Journal of Cutaneous Medicine, 9(1), p. s520. doi:10.25251/skin.9.supp.520.